> top > docs > PubMed:21507904 > annotations

PubMed:21507904 JSONTXT

Annnotations TAB JSON ListView MergeView

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-57 Sentence denotes Lectin microarray profiling of metastatic breast cancers.
TextSentencer_T2 58-164 Sentence denotes Altered protein glycosylation compared with the disease-free state is a universal feature of cancer cells.
TextSentencer_T3 165-361 Sentence denotes It has long been established that distinct glycan structures are associated with specific forms of cancer, but far less is known about the complete array of glycans associated with certain tumors.
TextSentencer_T4 362-563 Sentence denotes The cancer glycome has great potential as a source of biomarkers, but progress in this field has been hindered by a lack of available techniques for the elucidation of disease-associated glycosylation.
TextSentencer_T5 564-881 Sentence denotes In the present study, lectin microarrays consisting of 45 lectins with different binding preferences covering N- and O-linked glycans were coupled with evanescent-field activated fluorescent detection in the glycomic analysis of primary breast tumors and the serum and urine of patients with metastatic breast cancer.
TextSentencer_T6 882-1114 Sentence denotes A single 50 µm section of a primary breast tumor or <1 µL of breast cancer patient serum or urine was sufficient to detect glycosylation alterations associated with metastatic breast cancer, as inferred from lectin-binding patterns.
TextSentencer_T7 1115-1425 Sentence denotes The high-throughput, sensitive and relatively simple nature of the simultaneous analysis of N- and O-linked glycosylation following minimal sample preparation and without the need for protein deglycosylation makes the lectin microarray analysis described a valuable tool for discovery phase glycomic profiling.
T1 0-57 Sentence denotes Lectin microarray profiling of metastatic breast cancers.
T2 58-164 Sentence denotes Altered protein glycosylation compared with the disease-free state is a universal feature of cancer cells.
T3 165-361 Sentence denotes It has long been established that distinct glycan structures are associated with specific forms of cancer, but far less is known about the complete array of glycans associated with certain tumors.
T4 362-563 Sentence denotes The cancer glycome has great potential as a source of biomarkers, but progress in this field has been hindered by a lack of available techniques for the elucidation of disease-associated glycosylation.
T5 564-881 Sentence denotes In the present study, lectin microarrays consisting of 45 lectins with different binding preferences covering N- and O-linked glycans were coupled with evanescent-field activated fluorescent detection in the glycomic analysis of primary breast tumors and the serum and urine of patients with metastatic breast cancer.
T6 882-1114 Sentence denotes A single 50 µm section of a primary breast tumor or <1 µL of breast cancer patient serum or urine was sufficient to detect glycosylation alterations associated with metastatic breast cancer, as inferred from lectin-binding patterns.
T7 1115-1425 Sentence denotes The high-throughput, sensitive and relatively simple nature of the simultaneous analysis of N- and O-linked glycosylation following minimal sample preparation and without the need for protein deglycosylation makes the lectin microarray analysis described a valuable tool for discovery phase glycomic profiling.
T1 0-57 Sentence denotes Lectin microarray profiling of metastatic breast cancers.
T2 58-164 Sentence denotes Altered protein glycosylation compared with the disease-free state is a universal feature of cancer cells.
T3 165-361 Sentence denotes It has long been established that distinct glycan structures are associated with specific forms of cancer, but far less is known about the complete array of glycans associated with certain tumors.
T4 362-563 Sentence denotes The cancer glycome has great potential as a source of biomarkers, but progress in this field has been hindered by a lack of available techniques for the elucidation of disease-associated glycosylation.
T5 564-881 Sentence denotes In the present study, lectin microarrays consisting of 45 lectins with different binding preferences covering N- and O-linked glycans were coupled with evanescent-field activated fluorescent detection in the glycomic analysis of primary breast tumors and the serum and urine of patients with metastatic breast cancer.
T6 882-1114 Sentence denotes A single 50 µm section of a primary breast tumor or <1 µL of breast cancer patient serum or urine was sufficient to detect glycosylation alterations associated with metastatic breast cancer, as inferred from lectin-binding patterns.
T7 1115-1425 Sentence denotes The high-throughput, sensitive and relatively simple nature of the simultaneous analysis of N- and O-linked glycosylation following minimal sample preparation and without the need for protein deglycosylation makes the lectin microarray analysis described a valuable tool for discovery phase glycomic profiling.

Glycosmos6-MAT

Id Subject Object Predicate Lexical cue
T1 833-838 http://purl.obolibrary.org/obo/MAT_0000058 denotes urine
T2 974-979 http://purl.obolibrary.org/obo/MAT_0000058 denotes urine

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 151-157 HP_0002664 denotes cancer
T2 264-270 HP_0002664 denotes cancer
T3 354-360 HP_0002664 denotes tumors
T4 366-372 HP_0002664 denotes cancer
T5 801-814 HP_0003002 denotes breast tumors
T6 801-814 HP_0100013 denotes breast tumors
T7 808-814 HP_0002664 denotes tumors
T8 867-880 HP_0003002 denotes breast cancer
T9 867-880 HP_0100013 denotes breast cancer
T10 874-880 HP_0002664 denotes cancer
T11 918-930 HP_0003002 denotes breast tumor
T12 918-930 HP_0100013 denotes breast tumor
T13 925-930 HP_0002664 denotes tumor
T14 943-956 HP_0003002 denotes breast cancer
T15 943-956 HP_0100013 denotes breast cancer
T16 950-956 HP_0002664 denotes cancer
T17 1058-1071 HP_0003002 denotes breast cancer
T18 1058-1071 HP_0100013 denotes breast cancer
T19 1065-1071 HP_0002664 denotes cancer

GlycoBiology-FMA

Id Subject Object Predicate Lexical cue
_T1 42-48 FMAID:9601 denotes breast
_T2 42-48 FMAID:97486 denotes breast
_T3 66-73 FMAID:67257 denotes protein
_T4 66-73 FMAID:165447 denotes protein
_T5 158-163 FMAID:169002 denotes cells
_T6 158-163 FMAID:68646 denotes cells
_T7 801-807 FMAID:97486 denotes breast
_T8 801-807 FMAID:9601 denotes breast
_T9 823-828 FMAID:167330 denotes serum
_T10 833-838 FMAID:226785 denotes urine
_T11 867-873 FMAID:9601 denotes breast
_T12 867-873 FMAID:97486 denotes breast
_T13 895-896 FMAID:165145 denotes m
_T14 918-924 FMAID:97486 denotes breast
_T15 918-924 FMAID:9601 denotes breast
_T16 943-949 FMAID:97486 denotes breast
_T17 943-949 FMAID:9601 denotes breast
_T18 965-970 FMAID:167330 denotes serum
_T19 974-979 FMAID:226785 denotes urine
_T20 1058-1064 FMAID:97486 denotes breast
_T21 1058-1064 FMAID:9601 denotes breast
_T22 1299-1306 FMAID:165447 denotes protein
_T23 1299-1306 FMAID:67257 denotes protein

uniprot-mouse

Id Subject Object Predicate Lexical cue
T1 385-390 http://www.uniprot.org/uniprot/Q91ZZ5 denotes great

GlycoBiology-NCBITAXON

Id Subject Object Predicate Lexical cue
T1 49-56 http://purl.bioontology.org/ontology/NCBITAXON/6754 denotes cancers
T2 151-157 http://purl.bioontology.org/ontology/NCBITAXON/6754 denotes cancer
T3 158-163 http://purl.bioontology.org/ontology/STY/T025 denotes cells
T4 264-270 http://purl.bioontology.org/ontology/NCBITAXON/6754 denotes cancer
T5 366-372 http://purl.bioontology.org/ontology/NCBITAXON/6754 denotes cancer
T6 874-880 http://purl.bioontology.org/ontology/NCBITAXON/6754 denotes cancer
T7 950-956 http://purl.bioontology.org/ontology/NCBITAXON/6754 denotes cancer
T8 1065-1071 http://purl.bioontology.org/ontology/NCBITAXON/6754 denotes cancer

GO-BP

Id Subject Object Predicate Lexical cue
T1 66-87 http://purl.obolibrary.org/obo/GO_0006486 denotes protein glycosylation
T2 74-87 http://purl.obolibrary.org/obo/GO_0070085 denotes glycosylation
T3 549-562 http://purl.obolibrary.org/obo/GO_0070085 denotes glycosylation
T4 1005-1018 http://purl.obolibrary.org/obo/GO_0070085 denotes glycosylation
T5 1223-1236 http://purl.obolibrary.org/obo/GO_0070085 denotes glycosylation
T6 833-838 http://purl.obolibrary.org/obo/GO_0060073 denotes urine
T7 974-979 http://purl.obolibrary.org/obo/GO_0060073 denotes urine
T8 1136-1145 http://purl.obolibrary.org/obo/GO_0046960 denotes sensitive
T9 1214-1236 http://purl.obolibrary.org/obo/GO_0006493 denotes O-linked glycosylation
T10 1299-1322 http://purl.obolibrary.org/obo/GO_0006517 denotes protein deglycosylation

GO-MF

Id Subject Object Predicate Lexical cue
T1 645-652 http://purl.obolibrary.org/obo/GO_0070026 denotes binding
T2 1097-1104 http://purl.obolibrary.org/obo/GO_0070026 denotes binding
T3 645-652 http://purl.obolibrary.org/obo/GO_0003680 denotes binding
T4 1097-1104 http://purl.obolibrary.org/obo/GO_0003680 denotes binding
T5 645-652 http://purl.obolibrary.org/obo/GO_0017091 denotes binding
T6 1097-1104 http://purl.obolibrary.org/obo/GO_0017091 denotes binding
T7 645-652 http://purl.obolibrary.org/obo/GO_0005488 denotes binding
T8 1097-1104 http://purl.obolibrary.org/obo/GO_0005488 denotes binding
T9 1097-1113 http://purl.obolibrary.org/obo/GO_0001871 denotes binding patterns

GO-CC

Id Subject Object Predicate Lexical cue
T1 158-163 http://purl.obolibrary.org/obo/GO_0005623 denotes cells

UBERON-AE

Id Subject Object Predicate Lexical cue
T1 42-48 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
T2 801-807 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
T3 867-873 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
T4 918-924 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
T5 943-949 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
T6 1058-1064 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
T7 823-828 http://purl.obolibrary.org/obo/UBERON_0001977 denotes serum
T8 965-970 http://purl.obolibrary.org/obo/UBERON_0001977 denotes serum
T9 833-838 http://purl.obolibrary.org/obo/UBERON_0001088 denotes urine
T10 974-979 http://purl.obolibrary.org/obo/UBERON_0001088 denotes urine

GlycoBiology-MAT

Id Subject Object Predicate Lexical cue
T1 833-838 http://purl.obolibrary.org/obo/MAT_0000058 denotes urine
T2 974-979 http://purl.obolibrary.org/obo/MAT_0000058 denotes urine

performance-test

Id Subject Object Predicate Lexical cue
PD-UBERON-AE-B_T1 42-48 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T2 801-807 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T3 867-873 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T4 918-924 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T5 943-949 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T6 1058-1064 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T7 823-828 http://purl.obolibrary.org/obo/UBERON_0001977 denotes serum
PD-UBERON-AE-B_T8 965-970 http://purl.obolibrary.org/obo/UBERON_0001977 denotes serum
PD-UBERON-AE-B_T9 833-838 http://purl.obolibrary.org/obo/UBERON_0001088 denotes urine
PD-UBERON-AE-B_T10 974-979 http://purl.obolibrary.org/obo/UBERON_0001088 denotes urine

HP-phenotype

Id Subject Object Predicate Lexical cue hp_id
T1 42-56 Phenotype denotes breast cancers HP:0003002
T2 151-157 Phenotype denotes cancer HP:0002664
T3 264-270 Phenotype denotes cancer HP:0002664
T4 366-372 Phenotype denotes cancer HP:0002664
T5 801-814 Phenotype denotes breast tumors HP:0100013
T6 867-880 Phenotype denotes breast cancer HP:0003002
T7 918-930 Phenotype denotes breast tumor HP:0100013
T8 943-956 Phenotype denotes breast cancer HP:0003002
T9 1058-1071 Phenotype denotes breast cancer HP:0003002

mondo_disease

Id Subject Object Predicate Lexical cue mondo_id
T1 42-56 Disease denotes breast cancers http://purl.obolibrary.org/obo/MONDO_0007254
T2 151-157 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T3 264-270 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T4 354-360 Disease denotes tumors http://purl.obolibrary.org/obo/MONDO_0005070
T5 366-372 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T6 801-814 Disease denotes breast tumors http://purl.obolibrary.org/obo/MONDO_0007254|http://purl.obolibrary.org/obo/MONDO_0021100
T8 867-880 Disease denotes breast cancer http://purl.obolibrary.org/obo/MONDO_0007254
T9 918-930 Disease denotes breast tumor http://purl.obolibrary.org/obo/MONDO_0007254|http://purl.obolibrary.org/obo/MONDO_0021100
T11 943-956 Disease denotes breast cancer http://purl.obolibrary.org/obo/MONDO_0007254
T12 1058-1071 Disease denotes breast cancer http://purl.obolibrary.org/obo/MONDO_0007254

Lectin-Jamboree-Sentence

Id Subject Object Predicate Lexical cue
T1 0-57 Sentence denotes Lectin microarray profiling of metastatic breast cancers.
T2 58-164 Sentence denotes Altered protein glycosylation compared with the disease-free state is a universal feature of cancer cells.
T3 165-361 Sentence denotes It has long been established that distinct glycan structures are associated with specific forms of cancer, but far less is known about the complete array of glycans associated with certain tumors.
T4 362-563 Sentence denotes The cancer glycome has great potential as a source of biomarkers, but progress in this field has been hindered by a lack of available techniques for the elucidation of disease-associated glycosylation.
T5 564-881 Sentence denotes In the present study, lectin microarrays consisting of 45 lectins with different binding preferences covering N- and O-linked glycans were coupled with evanescent-field activated fluorescent detection in the glycomic analysis of primary breast tumors and the serum and urine of patients with metastatic breast cancer.
T6 882-1114 Sentence denotes A single 50 µm section of a primary breast tumor or <1 µL of breast cancer patient serum or urine was sufficient to detect glycosylation alterations associated with metastatic breast cancer, as inferred from lectin-binding patterns.
T7 1115-1425 Sentence denotes The high-throughput, sensitive and relatively simple nature of the simultaneous analysis of N- and O-linked glycosylation following minimal sample preparation and without the need for protein deglycosylation makes the lectin microarray analysis described a valuable tool for discovery phase glycomic profiling.

NCBITAXON

Id Subject Object Predicate Lexical cue db_id
T1 957-964 OrganismTaxon denotes patient 9606

Anatomy-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 42-48 Body_part denotes breast http://purl.obolibrary.org/obo/UBERON_0000310
T2 801-807 Body_part denotes breast http://purl.obolibrary.org/obo/UBERON_0000310
T3 833-838 Body_part denotes urine http://purl.obolibrary.org/obo/UBERON_0001088
T4 867-873 Body_part denotes breast http://purl.obolibrary.org/obo/UBERON_0000310
T5 918-924 Body_part denotes breast http://purl.obolibrary.org/obo/UBERON_0000310
T6 943-949 Body_part denotes breast http://purl.obolibrary.org/obo/UBERON_0000310
T7 974-979 Body_part denotes urine http://purl.obolibrary.org/obo/UBERON_0001088
T8 1058-1064 Body_part denotes breast http://purl.obolibrary.org/obo/UBERON_0000310

Anatomy-MAT

Id Subject Object Predicate Lexical cue mat_id
T1 833-838 Body_part denotes urine http://purl.obolibrary.org/obo/MAT_0000058
T2 974-979 Body_part denotes urine http://purl.obolibrary.org/obo/MAT_0000058

CL-cell

Id Subject Object Predicate Lexical cue cl_id
T1 151-163 Cell denotes cancer cells http://purl.obolibrary.org/obo/CL:0001064